- /
- Supported exchanges
- / US
- / LH.NYSE
Laboratory Corporation of America Holdings (LH NYSE) stock market data APIs
Laboratory Corporation of America Holdings Financial Data Overview
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; a strategic alliance with the National Association of Community Health Centers to support current and emerging clinical leaders through the NACHC Leadership Exchange for Chief Medical Officers; and Alliance for Clinical Trials in Oncology to advance national
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Laboratory Corporation of America Holdings (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Laboratory Corporation of America Holdings data using free add-ons & libraries
Get Laboratory Corporation of America Holdings Fundamental Data
Laboratory Corporation of America Holdings Fundamental data includes:
- Net Revenue: 14 348 M
- EBITDA: 2 320 M
- Earnings Per Share: 12
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Laboratory Corporation of America Holdings Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-07-30
- EPS/Forecast: 4.79
Get Laboratory Corporation of America Holdings End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Laboratory Corporation of America Holdings News
New
2 Volatile Stocks to Consider Right Now and 1 We Find Risky
2 Volatile Stocks to Consider Right Now and 1 We Find Risky Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This...
DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace?
Danaher Corporation's DHR Biotechnology segment remains a major growth driver. In the second quarter of 2026, the segment's reported sales increased 4% year over year to $1.92 billion. Its core revenu...
Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026
BURLINGTON, N.C., Sept. 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third...
Is This the Right Time to Add Labcorp Stock to Your Portfolio?
Labcorp Holdings Inc. LH, or Labcorp, is expanding in high-growth specialty testing markets while broadening its consumer testing business. Acquisitions, health-system relationships and new contracts ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.